Home
University of Bergen
Department of Clinical Medicine

News archive for Department of Clinical Medicine

Group photo.
Unveiling the journey of ovarian cancer patients (28.06.2024)
Karen Rosnes Gissum defended June 28, 2024 her PhD thesis "Unveiling the Complexities: Patients’ and Healthcare Providers’ Perspectives on Understanding and Managing Ovarian Cancer" at the University of Bergen. This is a unique CCBIO doctorate work focusing on the patient and healthcare worker perspective and not the actual research. Nevertheless, objective measures like biomarkers were seen as... Read more
Christiane in the lab.
Advanced 3D model for assessing efficacy of ovarian cancer therapy (27.06.2024)
In a new doctoral work at CCBIO, by Christiane Helgestad Gjerde, the group has established a 3D in vitro model of high-grade serous ovarian carcinoma to assess the efficacy of traditional chemotherapy and novel cell-based immunotherapies. This model makes out a more realistic mini tumor, making it possible to test which therapy that works on this type of cancer. The knowledge provided from this... Read more
Sunset photo from Rome.
Annual Scientific Congress 2024 Hosted by the Italian MS Society in Rome (May 28th-30th) (19.06.2024)
From May 28th to 30th, EBV-MS Partner Paola Zaratin, along with the Italian MS Society, hosted the Annual Scientific Congress 2024. Notable attendees included EBV-MS Project Coordinator Kjell-Morten Myhr, Deputy Project Coordinator Øivind Torkildsen, and project partner Marco Salvetti from Sapienza University of Rome, all invited by the Italian MS Society, ensuring significant representation from... Read more
Illustration of a board meeting room.
Inaugural Session: Our First Meeting with the Scientific Advisory Board (19.06.2024)
On Wednesday, June 5th, 2024, a productive introduction between the consortium and the Scientific Advisory Board (SAB) was conducted during a recent gathering. The meeting marked a positive commencement of the collaboration between the SAB and the members of the EBV-MS project.
Collage of meeting participants and speakers.
EBV-MS Kick-off: January 23rd -24th (19.06.2024)
On Tuesday, January 23rd, and Wednesday, January 24th, 2024, the EBV-MS project successfully held its inaugural kick-off meeting. This meeting provided an opportunity for the project team to get acquainted, share insights, and set goals. The program was structured to cover various aspects of the project, including the introduction of partners, presentation of work packages, and discussions on... Read more
Photo of Ole and Heidrun working in the lab.
Nerves can affect breast cancer (18.06.2024)
The doctoral work of Ole Vidhammer Bjørnstad, which includes three coming scientific papers, has shed light on the occurrence of neural precursor cells in breast cancer, and the interactions between neural precursor cells and breast cancer cells.
members of the renal research group together with Prof. lx and Prof. Hallan.
Prof. Joachim lx (UC, San Diego) & Prof. Stein Hallan (NTNU) vist the Renal Research Group (UiB) (17.06.2024)
Prof. Ix is Professor and Division Chief in the Department of Medicine, Division of Nephrology-Hypertension (UC San Diego) & Prof. Stein Ivar Hallan (Specialist in internal medicine, kidney diseases and clinical chemistry) were both visting the Renal Research Group at University of Bergen to discuss future collaboration between the three research groups (June 10th 2024).
Portrait photo of Bob Langer at the CCBIO symposium.
The 2024 Kavli Prize in Nanoscience awarded to Professor Robert S. Langer (13.06.2024)
The Norwegian Academy of Science and Letters June 12th announced the 2024 Kavli Prize Laureates in the fields of astrophysics, nanoscience and neuroscience. Among these are Robert S. Langer (USA), sharing the 2024 Kavli Prize in Nanoscience with Armand Paul Alivisatos (USA) and Chad A. Mirkin (USA).
Jeanette sitting with her computer in the group meeting, with the view of the fjord from Solstrand Hotel in the back.
Patient involvement in cancer biomarker research is a work in progress (05.06.2024)
Although patient involvement in research was not part of the program at the 12th CCBIO Annual Symposium, it is a topic CCBIO will give more attention to. We had a chat with a user representative who participated at the symposium, and who is also contributing in one of our research projects.
The SAB members and the CCBIO management standing on the stairs outside the Solstrand Hotel.
Continuing a strong cancer research network (05.06.2024)
The 12th CCBIO Annual Symposium has recently taken place, with a program showcasing current cancer biomarker research. This was the final symposium in CCBIO’s 10-year period funded by the Research Council of Norway as a Centre of Excellence (CoE), however not the last. CCBIO will continue its core activities, maintaining what has become a strong cancer research network.
Collage of all group members.
Targeting tumor aggressiveness in young breast cancer patients (05.06.2024)
Although CCBIO this summer completes its 10-year appointment as Center of Excellence by the Research Council of Norway, the center will continue its activities, and so do all the research groups and collaborations that have been established through these years. It has been a privilege for the CCBIO leadership to follow these groups from the very beginning and watch them grow and now continue to... Read more